Transcription Factors – Normal and Malignant Development of Blood Cells
Seiten
2002
John Wiley & Sons Inc (Hersteller)
978-0-471-22388-7 (ISBN)
John Wiley & Sons Inc (Hersteller)
978-0-471-22388-7 (ISBN)
- Keine Verlagsinformationen verfügbar
- Artikel merken
Hematopoiesis is controlled by the combined effect of growth factors that promote cellular proliferation and nuclear factors (transcription factors) that induce the expression of lineage-specific genes and, hence, promote specific lineage development. This work offers a coverage of the myriad of transcription factors in blood cell development.
"Transcription Factors: Normal and Malignant Development of Blood Cells" is written by Katya Ravid and Jonathan Licht. The role of transcription factors in activating specific genes in blood cells is an important facet of hematopoiesis. Equally important, however, is the pursuit of genes rearranged and aberrantly activated in leukemias (blood malignancies). "Transcription Factors: Normal and Malignant Development of Blood Cells" focuses on those major transcription factors involved in activation of lineage-specific gene expression during normal versus malignant development of specific blood lineages, as revealed from gene promoter studies, knockout of transcription factors in mice models, and the identification and characterization of chromosomal rearrangement in human blood leukemias. This complete digest of current transcription factor data offers comprehensive coverage of the myriad of transcription factors in blood cell development, composed by established experts in the field.
In addition to updating the reader on the connection between chromosomal translocations involving transcription factors and cellular transformation leading to leukemia, "Transcription Factors" also reviews such subjects as: transcription factors and the megakaryocytic, myeloid, and erythroid lineages, leukemias due to chromosomal translocations involving gene encoding transcription factors, oncogenesis and hematopoiesis, in vivo studies of transcription factors implicated in hematopoiesis, and much more. Appealing to both the researcher and the clinician in the field of hematology, "Transcription Factors" is a timely presentation of cell lineage development and sheds light on the processes involved in the development of specific leukemias. Providing insight into the study of transcription factors, readers will gain an understanding of mechanisms that lead to normal lineage commitment and terminal differentiation.
"Transcription Factors: Normal and Malignant Development of Blood Cells" is written by Katya Ravid and Jonathan Licht. The role of transcription factors in activating specific genes in blood cells is an important facet of hematopoiesis. Equally important, however, is the pursuit of genes rearranged and aberrantly activated in leukemias (blood malignancies). "Transcription Factors: Normal and Malignant Development of Blood Cells" focuses on those major transcription factors involved in activation of lineage-specific gene expression during normal versus malignant development of specific blood lineages, as revealed from gene promoter studies, knockout of transcription factors in mice models, and the identification and characterization of chromosomal rearrangement in human blood leukemias. This complete digest of current transcription factor data offers comprehensive coverage of the myriad of transcription factors in blood cell development, composed by established experts in the field.
In addition to updating the reader on the connection between chromosomal translocations involving transcription factors and cellular transformation leading to leukemia, "Transcription Factors" also reviews such subjects as: transcription factors and the megakaryocytic, myeloid, and erythroid lineages, leukemias due to chromosomal translocations involving gene encoding transcription factors, oncogenesis and hematopoiesis, in vivo studies of transcription factors implicated in hematopoiesis, and much more. Appealing to both the researcher and the clinician in the field of hematology, "Transcription Factors" is a timely presentation of cell lineage development and sheds light on the processes involved in the development of specific leukemias. Providing insight into the study of transcription factors, readers will gain an understanding of mechanisms that lead to normal lineage commitment and terminal differentiation.
Katya Ravid is the editor of Transcription Factors: Normal and Malignant Development of Blood Cells, published by Wiley. Jonathan D. Licht is the editor of Transcription Factors: Normal and Malignant Development of Blood Cells, published by Wiley.
| Erscheint lt. Verlag | 1.4.2002 |
|---|---|
| Verlagsort | New York |
| Sprache | englisch |
| Maße | 150 x 250 mm |
| Gewicht | 666 g |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Hämatologie |
| Studium ► 1. Studienabschnitt (Vorklinik) ► Physiologie | |
| ISBN-10 | 0-471-22388-3 / 0471223883 |
| ISBN-13 | 978-0-471-22388-7 / 9780471223887 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
